NORTHERN TRUST CORP - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 41 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q3 2023$3,535
-2.5%
39,4140.0%0.00%
Q2 2023$3,626
-64.6%
39,4140.0%0.00%
Q1 2023$10,248
+23.8%
39,4140.0%0.00%
Q4 2022$8,277
-17.2%
39,4140.0%0.00%
Q3 2022$10,000
-64.3%
39,4140.0%0.00%
Q2 2022$28,000
-9.7%
39,4140.0%0.00%
Q1 2022$31,000
-20.5%
39,4140.0%0.00%
Q4 2021$39,000
-43.5%
39,4140.0%0.00%
Q3 2021$69,000
-4.2%
39,4140.0%0.00%
Q2 2021$72,000
-10.0%
39,4140.0%0.00%
Q1 2021$80,000
-3.6%
39,414
+1.5%
0.00%
Q4 2020$83,000
-14.4%
38,813
+7.8%
0.00%
Q3 2020$97,000
-46.1%
35,991
-21.4%
0.00%
Q2 2020$180,000
+1025.0%
45,794
+108.6%
0.00%
Q1 2020$16,000
-40.7%
21,9510.0%0.00%
Q4 2019$27,000
+237.5%
21,951
+79.4%
0.00%
Q3 2019$8,0000.0%12,2340.0%0.00%
Q2 2019$8,00012,2340.00%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q2 2020
NameSharesValueWeighting ↓
Allred Capital Management, LLC 65,303$176,0000.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 132,540$358,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 51,648$139,0000.00%
PATHSTONE FAMILY OFFICE, LLC 10,050$28,0000.00%
LifePlan Financial Group, Inc 1,440$4,0000.00%
Sowell Financial Services LLC 11,234$30,0000.00%
Jacobi Capital Management LLC 1,000$3,0000.00%
TWO SIGMA INVESTMENTS, LP 65,089$176,0000.00%
Sound Income Strategies, LLC 599$2,0000.00%
UBS Group AG 1,785$5,0000.00%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders